Why the study?
To address the neutralising mechanisms of antibodies to rhinoviruses to help progress vaccine development.
Design
Review
Authors
Loading...
May guide rhinovirus vaccine design targeting capsid epitopes; leaves open which mechanisms predominate in humans.
This review outlines at least five mechanisms by which antibodies neutralize rhinoviruses, providing insights that could influence future vaccine design.
Touabi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: